The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the resulting public health threat from extensively drug-resistant TB, globally and in Canada

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 18, Issue 5, 2007, Pages 289-291

  Alexander, Paul E ^a,c   De, Prithwish ^b  

^a HEALTH CANADA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NONE   (Canada)

Author keywords

Coinfection; Drug resistance; HIV; MDR TB; TB HIV; Tuberculosis; XDR TB

Indexed keywords

AMIKACIN; CAPREOMYCIN; KANAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; CANADA; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; LUNG TUBERCULOSIS; MULTIDRUG RESISTANCE; PUBLIC HEALTH; REVIEW; SUPERINFECTION; VIRUS TRANSMISSION;

EID: 36749102546     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/986794     Document Type: Review

References (23)

1. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-21.
2. UNAIDS. UNAIDS/WHO "AIDS epidemic update: December 2006". 〈http://www.unaids.org/en/HIV_data/epi2006/default.asp〉 (Version current at July 26, 2007).
3. UNAIDS/WHO. AIDS epidemic update, December 2002. 〈http://data. unaids.org/Publications/IRC-pub03/epiupdate2002_en.pdf〉 (Version current at July 26, 2007).
4. World Health Organization, AIDS Epidemic update: December 2003. 〈http://www.who.int/hiv/pub/epidemiology/epi2003/en/index.html〉 (Version current at July 26, 2007).
5. Raviglione MC, Harries AD, Msiska R, Wilkinson D, Nunn P. Tuberculosis and HIV: Current status in Africa. AIDS 1997;11(Suppl B):S115-23.
6. Cantwell MF, Binkin NJ. Impact of HIV on tuberculosis in sub-Saharan Africa: A regional perspective. Int J Tuberc Lung Dis 1997;1:205-14.
7. Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996;157:1271-8.
8. Toossi Z. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. J Infect Dis 2003;188:1146-55.
9. JP Narain, ed. Tuberculosis: Epidemiology and Control, 2002. New Delhi: World Health Organization Regional Office for SouthEast Asia, 2002.
10. Cosivi O, Grange JM, Daborn CJ, et al. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis 1998;4:59-70.
11. Zachariah R, Teck R, Ascurra O, et al. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi? Int J Tuberc Lung Dis 2005;9:238-47.
12. Frieden TR, Sherman LF, Maw KL, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: Epidemiology and clinical outcomes. JAMA 1996;276:1229-35.
13. Beck-Sagué C, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA 1992;268:1280-6.
14. Yang H, Field SK, Fisher DA, Cowie RL. Tuberculosis in Calgary, Canada, 1995-2002: Site of disease and drug susceptibility. Int J Tuberc Lung Dis 2005;9:288-93.
15. Campos PE, Suarez PG, Sanchez J, et al. Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Emerg Infect Dis 2003;9:1571-8.
16. Punnotok J, Shaffer N, Naiwatanakul T, et al. Human immuno-deficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand. Int J Tuberc Lung Dis 2000;4:537-43.
17. Masjedi MR, Farnia P, Sorooch S, et al. Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis 2006;43:841-7.
18. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-80.
19. World Health Organization - tuberculosis (TB). XDR-TB extensively drug-resistant tuberculosis. 〈http://www.who.int/tb/xdr/en/index.html〉 (Version current at July 26, 2007).
20. World Health Organization. Emergence of XDR-TB: WHO concern over extensive drug resistant TB strains that are virtually untreatable. 〈http://www.who.int/mediacentre/news/notes/2006/np23/en/index.html〉 (Version current at July 26, 2007).
21. Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-5.
22. Dahle UR. Extensively drug resistant tuberculosis: Beware patients lost to follow-up. BMJ 2006;333:705.
23. Raviglione MC, Smith IM. XDR tuberculosis - implications for global public health. N Engl J Med 2007;356:656-9.